Nashville, TN, United States of America

Dawn B Beaulieu

This inventor holds 1 USPTO granted patent. Top assignee: Vanderbilt University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dawn B Beaulieu. Retrieved from https://idiyas.com/inventor/dawn-b-beaulieu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Dawn B Beaulieu in Gastrointestinal Treatment

Introduction

Dawn B Beaulieu is a notable inventor based in Nashville, TN (US). She has made significant contributions to the field of medicine, particularly in the treatment of gastrointestinal motility disorders. Her innovative approach has led to the development of effective methods that address these complex health issues.

Latest Patents

Dawn B Beaulieu holds 1 patent for her work titled "Methods of treatment for gastrointestinal motility disorders." This patent discloses methods for treating or reducing symptoms of gastrointestinal motility disorders in a subject. The methods include administering a therapeutically effective amount of a sodium channel blocker compound, showcasing her commitment to advancing medical treatments.

Career Highlights

Dawn is affiliated with Vanderbilt University, where she continues her research and development in the medical field. Her work is characterized by a focus on innovative solutions that improve patient outcomes.

Collaborations

Dawn collaborates with esteemed colleagues such as Jill M Pulley and Rebecca N Jerome, enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Dawn B Beaulieu's contributions to the treatment of gastrointestinal motility disorders exemplify the importance of innovation in medicine. Her work not only advances scientific understanding but also offers hope for improved patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…